The utility and safety of intraperitoneal administration by microbubble agents for cirrhosis with refractory ascites

The utility and safety of intraperitoneal administration by microbubble agents for cirrhosis with refractory ascites - Intraperitoneal administration by microbubble agents for refractory ascites

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014861

Enrollment

Registered

2014-08-15

Start date

2014-08-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis with refractory ascites

Interventions

Contrast-enhanced ultrasound

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cirrotic patients with refractory ascites

Exclusion criteria

Exclusion criteria: ?Child-Pugh grade C ?Egg allergy ?Spontaneous bacterial peritonitis

Design outcomes

Primary

Measure	Time frame
The safety of intraperitoneal administration by microbubble contrast agents	—

Secondary

Measure	Time frame
Transit time to circulation of blood from the time of intraperitoneal administration by microbubble contrast agents	—

Countries

Japan

Contacts

Public ContactTadashi Sekimoto

Chiba University Graduate School of Medicine Department of Gastroenterology and Nephrology

tad_sekimoto@chiba-u.jp043-226-2083

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026